Critical Therapeutics, Inc. Announces Stock Listing Transfer From NASDAQ Global Market to NASDAQ Capital Market

LEXINGTON, Mass.--(BUSINESS WIRE)--Critical Therapeutics, Inc. (NASDAQ: CRTX) announced today that it received approval from the NASDAQ Stock Market’s Listing Qualifications Staff to transfer the listing of its common stock from The NASDAQ Global Market to The NASDAQ Capital Market. The transfer is effective at the opening of business on June 17, 2008. Critical Therapeutics’ NASDAQ trading symbol will remain “CRTX.”